65--Xellia Pharmaceuticals 09/15/2019 - 09/14/2024
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the NAC Federal Supply Schedule (36F797), has awarded Contract 36F79726D0079 to Mesoblast, Inc. for Drugs and Biologicals (PSC 6505). This award is effective from February 15, 2026, to February 14, 2031. The award amount is listed as $0.00, which is typical for an Indefinite Delivery, Indefinite Quantity (IDIQ) contract where funds are obligated via subsequent task orders.
Scope of Award
This contract covers the provision of Drugs and Biologicals, falling under Product/Service Code 6505 and NAICS Code 325412 (Pharmaceutical Preparation Manufacturing). The award is associated with Solicitation Number M5-Q50A-03-R8.
Contract & Timeline
- Awardee: Mesoblast, Inc.
- Agency: Department of Veterans Affairs, NAC Federal Supply Schedule
- Contract Number: 36F79726D0079
- Type: Award Notice (likely IDIQ)
- Duration: 5 years (February 15, 2026 - February 14, 2031)
- Value: $0.00
- Set-Aside: None specified
- Award Date: February 13, 2026 (published date)
Additional Information
This award notice confirms the contract to Mesoblast, Inc. for the specified period. For further information, the VA Federal Supply Schedule (FSS) Help Desk can be contacted at FSS.Help@va.gov or (708) 786-7737.